The Department of Justice just fired its second shot across the bow of America’s most powerful hospital systems. If you’re a physician practicing in Florida, you should be paying close attention.

On March 26, the DOJ’s Antitrust Division and the U.S. Attorney’s Office for the Southern District of New York filed a civil antitrust lawsuit against NewYork-Presbyterian, the largest hospital system in New York City. The charge: wielding market dominance to force insurers into anticompetitive contracts that block patients from accessing lower-cost care. It comes just five weeks after an almost identical suit against OhioHealth.

Two lawsuits in five weeks. Same playbook alleged in both. The federal government is telling America’s dominant hospital systems that the free ride is over.

The Playbook: “All-or-Nothing” Contracts

The complaint against NewYork-Presbyterian reads like a case study in market abuse. The system operates eight hospitals and numerous outpatient facilities across New York City. According to the Antitrust Division, it imposed contract restrictions on insurers that prevented them from offering patients budget-conscious health plans.

The tactics are brazen but familiar to anyone who has watched hospital consolidation reshape American healthcare — a pattern we’ve covered extensively in our analysis of how insurance is reshaping medicine from the inside. NewYork-Presbyterian allegedly required insurers to include all of its hospitals in their networks or exclude them entirely. It imposed anti-steering and anti-tiering clauses that prohibited insurers from guiding patients toward lower-cost competitors. And it enforced what the DOJ called “gag provisions,” contractual terms that prevented health plans from even telling patients that cheaper options existed.

Think about that for a moment. A hospital system so powerful that insurers couldn’t tell their own members where to find a better deal.

Acting Assistant Attorney General Omeed Assefi didn’t mince words. He said NewYork-Presbyterian knew consumers wanted budget-conscious health plans but chose to protect its margins and impede competition rather than compete on value. Attorney General Pamela Bondi was equally direct, stating that millions of New Yorkers pay more for healthcare because of these practices.

The February lawsuit against OhioHealth tells the same story in a different city. The DOJ and Ohio’s Attorney General alleged that OhioHealth, which holds more than 35% of the Columbus market, has used identical contracting tactics since at least 2003 to prevent insurers from offering affordable alternatives. The government called OhioHealth a “must-have” system, meaning insurers literally cannot sell competitive products in Columbus without including it. That kind of market position gives a system extraordinary power to dictate terms.

Why This Matters for Florida

Florida physicians might look at lawsuits in New York and Ohio and wonder why they should care. The answer is straightforward.

The contracting practices the DOJ is targeting are not unique to those two systems. They are standard procedure across America’s consolidated hospital markets. And Florida’s hospital market is among the most consolidated in the country.

HCA Healthcare, the nation’s largest for-profit hospital operator, runs a massive Florida operation with 71 freestanding emergency rooms and more opening every quarter. AdventHealth operates 54 hospitals across the state, with its most recent acquisition, a $265 million purchase of ShorePoint Health facilities in Port Charlotte, closing just weeks ago. Baptist Health, Orlando Health, and BayCare round out a market where a handful of systems control entire regions.

When these systems negotiate with insurers, they carry the same weight that landed NewYork-Presbyterian and OhioHealth in federal court. All-or-nothing bundling, anti-steering clauses, and tiering restrictions aren’t New York problems or Ohio problems. They are structural features of concentrated hospital markets. Florida’s markets are deeply concentrated — and the downstream consequences for patients are devastating, as we documented in The Fragmented Patient: How Healthcare’s Assembly-Line Model Is Failing Florida Families.

The implications for physicians hit close to home. When dominant hospital systems dictate insurance network terms, they shape the competitive environment in which every physician practices. Independent practices and smaller hospital systems find themselves squeezed, unable to compete on price because insurers can’t steer patients their way, even when they offer better value. The market ends up rewarding size over quality, market position over outcomes. It’s a dynamic that fuels the physician burnout and moral injury crisis we’ve been tracking across the state.

There’s a Florida-specific wrinkle worth noting. Earlier this year, the state Legislature considered HB 1047, a bill that would have granted hospital districts and their private partners broad immunity from antitrust scrutiny through joint ventures — one of several alarming proposals we tracked in our Week 5 legislative session roundup. Critics called it a “backdoor merger” that would weaken competition and shield public entities from oversight. The bill stalled in committee. But the fact that it was filed at all tells you which direction some interests in Tallahassee have been pushing.

The DOJ’s aggressive enforcement changes that calculus. Hospital systems and their lobbyists can no longer assume that anticompetitive behavior will go unchallenged at the federal level.

What Florida Physicians Should Do Now

1. Know which systems dominate your region and how their insurer contracts affect your ability to compete. If you’re losing patients not because of quality but because of network design, anticompetitive contracting may be the reason. Our deep dive into prior authorization practices in Florida shows how these contracting dynamics play out at the clinical level. Ask the questions.

2. Review your own payer contracts for anti-steering clauses, tiering restrictions, or all-or-nothing bundling requirements that limit your patients’ choices. If you’re employed by a large system, take the time to understand how your employer’s contracting practices shape the market around you.

3. Get involved with the Florida Medical Association. The FMA has been tracking hospital consolidation and its impact on physician practice for years. As the DOJ ramps up enforcement, organized medicine needs to be at the table, actively advocating for market structures that reward quality and protect patient choice.

4. Champion price transparency. The DOJ’s cases highlight the real damage done by gag provisions that prevent insurers from sharing cost information with patients. Transparent markets are the ones where clinical excellence actually gets rewarded.

5. Watch Tallahassee as closely as Washington. The next Florida legislative session will almost certainly see new attempts to shield hospital systems from competition. Physician voices need to be loud and early in those debates, not showing up after the bills have already been drafted.

The Bigger Picture

These lawsuits signal something larger than two legal cases. They represent a bipartisan recognition that hospital consolidation has gone too far — something we’ve explored in depth in The Human Cost of Florida’s Health Care Crisis. The same market power that was supposed to deliver efficiency has instead delivered higher costs, fewer choices, and a healthcare system where the biggest players write the rules.

For physicians, this is both a warning and an opening. The forces that drive anticompetitive behavior in hospital systems also erode physician autonomy, compress reimbursements, and hollow out practice independence. Combined with federal policy shifts like the CMS GENEROUS Model, a federal government willing to challenge dominant hospital systems creates space for the kind of market reforms that organized medicine has been pushing for years.

The question is whether Florida’s physicians will step into that space or watch from the sidelines while the rules get rewritten without them.

Frequently Asked Questions

What did the DOJ allege against NewYork-Presbyterian in the March 2026 antitrust lawsuit?

The Department of Justice alleged that NewYork-Presbyterian violated Section 1 of the Sherman Act by imposing anticompetitive contract restrictions on insurers. These included all-or-nothing bundling that forced insurers to include all NYP hospitals or none, anti-steering and anti-tiering clauses that prevented insurers from directing patients to lower-cost competitors, and gag provisions that blocked insurers from sharing pricing information with patients.

How does the DOJ’s hospital antitrust enforcement affect Florida physicians?

Florida’s hospital market is among the most consolidated in the nation, with HCA Healthcare, AdventHealth, and other large systems dominating regional markets. The same contracting practices the DOJ targeted in New York and Ohio are common in concentrated markets nationwide. Florida physicians should expect increased federal scrutiny of these practices in their state.

What is an “all-or-nothing” hospital contract and why is it anticompetitive?

An all-or-nothing contract requires an insurer to include every hospital in a system’s network or exclude them all. This prevents insurers from selectively contracting with only the most cost-effective facilities, eliminates price competition between individual hospitals, and forces patients into higher-cost networks even when affordable alternatives exist nearby.

What can Florida physicians do to address hospital anticompetitive practices in their market?

Physicians should review their payer contracts for anti-steering and tiering restrictions, engage with the Florida Medical Association’s advocacy efforts on hospital consolidation, champion price transparency initiatives, and actively participate in state legislative debates about hospital competition and antitrust immunity proposals.

Is the DOJ likely to bring similar antitrust cases against Florida hospital systems?

While no Florida-specific cases have been announced, the DOJ’s Antitrust Division has signaled that its hospital enforcement campaign is ongoing. Acting AAG Omeed Assefi stated the Division will continue to hold hospitals violating the antitrust laws accountable. Florida’s highly consolidated hospital markets and a recently proposed state bill that would have granted antitrust immunity to hospital joint ventures suggest the state could attract federal attention.